Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03245437 · ClinicalTrials.gov registry record · Phase 4
Target Engagement and Response to Oxytocin
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT03245437 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 120 participants.
The verdict
NCT03245437, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will measure whether the engagement of intranasal oxytocin with a brain target is related to effects on learning during a social cognition training program.
Interventions
- DRUG Oxytocin nasal spray
- DRUG Placebo nasal spray
- BEHAVIORAL Social Cognition Skills Training
- BEHAVIORAL Health Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-01-04 |
| Est. Completion | 2024-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03245437
The ClinicalTrials.gov registry entry for NCT03245437 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Oxytocin nasal spray is the first listed.
NCT03245437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03245437 about?
NCT03245437 is a clinical study titled "Target Engagement and Response to Oxytocin". This study will measure whether the engagement of intranasal oxytocin with a brain target is related to effects on learning during a social cognition training program.
What is the current status of trial NCT03245437?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2018-01-04. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT03245437?
The interventions under investigation include: Oxytocin nasal spray (DRUG), Placebo nasal spray (DRUG), Social Cognition Skills Training (BEHAVIORAL), Health Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03245437?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.